Search research articles
Contact Us
Filters
Showing results (1-10 of 65) with videos related to
Page
of 7
Sort By:
Neurology
|
March 25, 2020
Reader response: Lipid levels and the risk of hemorrhagic stroke among women
Laurens F Reeskamp, Renate M Hoogeveen
NEJM Evidence
|
October 28, 2025
Low-Density Lipoprotein Cholesterol and Coronary Artery Disease across Ancestries - Equal Direction, Different Magnitude?
Nick S Nurmohamed, Laurens F Reeskamp
Science Bulletin
|
January 19, 2023
Studies into the association between LDL-C lowering and cognitive function: time to forget about it?
Shirin Ibrahim, Laurens F Reeskamp, G Kees Hovingh
Journal of the American College of Cardiology
|
May 18, 2019
Hypercholesterolemia Among Premature Infarcts: Time to Start the Clock of Familial Hypercholesterolemia Assessment
G Kees Hovingh, Laurens F Reeskamp, Kausik K Ray
Current Opinion in Lipidology
|
September 11, 2024
Effectiveness of cascade screening for elevated lipoprotein(a), an underdiagnosed family disorder
Maxim E Annink, Emma S Janssen, Laurens F Reeskamp
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 22, 2021
Letter by Tromp et al Regarding Article, "Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland"
Tycho R Tromp, G Kees Hovingh, Laurens F Reeskamp
European Journal of Preventive Cardiology
|
November 23, 2019
PCSK9 as predictor for recurrent cardiovascular disease in familial hypercholesterolemia
Laurens F Reeskamp, Tycho R Tromp, G Kees Hovingh
Journal of the American College of Cardiology
|
May 23, 2020
Familial Hypercholesterolemia: The Most Common Monogenic Disorder in Humans
John J P Kastelein, Laurens F Reeskamp, G Kees Hovingh
JACC. Advances
|
October 7, 2024
Familial Hypercholesterolemia Detection Through Machine Learning Algorithms: A Low-Hanging Fruit
Laurens F Reeskamp, Maxim E Annink, Willemijn A M Schonck
Current Opinion in Lipidology
|
April 24, 2020
The next generation of triglyceride-lowering drugs: will reducing apolipoprotein C-III or angiopoietin like protein 3 reduce cardiovascular disease?
Laurens F Reeskamp, Tycho R Tromp, Erik S G Stroes
Page
of 7
Search research articles
Search
Showing results (1-10 of 65) with videos related to
Sort By:
Page
of 7
Neurology
|
March 25, 2020
Reader response: Lipid levels and the risk of hemorrhagic stroke among women
Laurens F Reeskamp, Renate M Hoogeveen
NEJM Evidence
|
October 28, 2025
Low-Density Lipoprotein Cholesterol and Coronary Artery Disease across Ancestries - Equal Direction, Different Magnitude?
Nick S Nurmohamed, Laurens F Reeskamp
Science Bulletin
|
January 19, 2023
Studies into the association between LDL-C lowering and cognitive function: time to forget about it?
Shirin Ibrahim, Laurens F Reeskamp, G Kees Hovingh
Journal of the American College of Cardiology
|
May 18, 2019
Hypercholesterolemia Among Premature Infarcts: Time to Start the Clock of Familial Hypercholesterolemia Assessment
G Kees Hovingh, Laurens F Reeskamp, Kausik K Ray
Current Opinion in Lipidology
|
September 11, 2024
Effectiveness of cascade screening for elevated lipoprotein(a), an underdiagnosed family disorder
Maxim E Annink, Emma S Janssen, Laurens F Reeskamp
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 22, 2021
Letter by Tromp et al Regarding Article, "Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland"
Tycho R Tromp, G Kees Hovingh, Laurens F Reeskamp
European Journal of Preventive Cardiology
|
November 23, 2019
PCSK9 as predictor for recurrent cardiovascular disease in familial hypercholesterolemia
Laurens F Reeskamp, Tycho R Tromp, G Kees Hovingh
Journal of the American College of Cardiology
|
May 23, 2020
Familial Hypercholesterolemia: The Most Common Monogenic Disorder in Humans
John J P Kastelein, Laurens F Reeskamp, G Kees Hovingh
JACC. Advances
|
October 7, 2024
Familial Hypercholesterolemia Detection Through Machine Learning Algorithms: A Low-Hanging Fruit
Laurens F Reeskamp, Maxim E Annink, Willemijn A M Schonck
Current Opinion in Lipidology
|
April 24, 2020
The next generation of triglyceride-lowering drugs: will reducing apolipoprotein C-III or angiopoietin like protein 3 reduce cardiovascular disease?
Laurens F Reeskamp, Tycho R Tromp, Erik S G Stroes
Page
of 7